Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€0.81
05.11.23
-
05.11.24
15.43%
11.11.23

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
buy
Merck KGaA

Start price
Target price
Perf. (%)
€137.25
30.10.23
-
30.11.23
10.27%
10.11.23

buy
Merck KGaA

Start price
Target price
Perf. (%)
€170.60
09.11.22
-
09.11.23
-10.11%
10.11.23

buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€1.01
03.09.23
-
03.09.24
-19.80%
05.11.23

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
buy
Sartorius AG VZO

Start price
Target price
Perf. (%)
€354.20
29.08.23
€450.00
29.08.24
-35.43%
25.10.23

buy
Heidelberg Pharma AG

Start price
Target price
Perf. (%)
€5.52
21.10.22
-
21.10.23
-46.56%
22.10.23

buy
B.R.A.I.N. Biotechnology Research and Information Network AG

Start price
Target price
Perf. (%)
€5.42
15.10.22
-
15.10.23
-24.91%
16.10.23

buy
Fresenius Medical Care AG & Co KGaA ST

Start price
Target price
Perf. (%)
€32.22
11.10.23
-
11.10.24
0.74%
14.10.23

buy
B.R.A.I.N. Biotechnology Research and Information Network AG

Start price
Target price
Perf. (%)
€4.98
13.10.22
-
13.10.23
-18.27%
14.10.23

Fresenius Medical Care AG & Co KGaA ST

Start price
Target price
Perf. (%)
€38.99
04.10.23
€22.00
04.10.24
-16.75%
14.10.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
buy
Vita 34 AG

Start price
Target price
Perf. (%)
€4.76
19.09.23
€6.00
19.09.24
-1.68%
30.09.23

Very Future proof/growth oriented business model
Market Leader or Top 3
Could be very worthwhile Investment >20% year
Rising EBIT margin expected
buy
Vita 34 AG

Start price
Target price
Perf. (%)
€4.79
07.09.23
-
07.09.24
-4.59%
16.09.23

Very Future proof/growth oriented business model
Market Leader or Top 3
Could be very worthwhile Investment >20% year
Rising EBIT margin expected
buy
Gerresheimer AG

Start price
Target price
Perf. (%)
€122.70
04.09.23
-
04.10.23
-14.91%
12.09.23

Paion AG

Start price
Target price
Perf. (%)
€0.90
08.09.22
€0.000
08.09.23
-24.53%
09.09.23

Innovative
Future proof or reliable business model
Could be very worthwhile Investment >20% year
Strong uniques
buy
Fresenius Medical Care AG & Co KGaA ST

Start price
Target price
Perf. (%)
€48.14
18.07.23
€50.00
18.07.24
-15.97%
08.09.23

buy
MorphoSys AG

Start price
Target price
Perf. (%)
€29.00
27.08.23
-
27.08.24
-2.90%
03.09.23

ifa systems AG

Start price
Target price
Perf. (%)
€3.16
20.08.23
€0.000
20.08.24
-5.70%
03.09.23

Revenue decline/stagnation expected
Decining EBIT margin than peer group
EBIT decline/stagnation expected
High valuation
buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€29.39
25.08.23
-
25.08.24
0.20%
02.09.23

buy
Formycon AG

Start price
Target price
Perf. (%)
€57.20
08.08.21
€99.00
13.10.23
6.29%
28.08.23

buy
Biofrontera AG

Start price
Target price
Perf. (%)
€1.28
25.08.22
€2.00
25.08.23
-56.24%
26.08.23

buy
Drägerwerk AG & Co. KGaA ST

Start price
Target price
Perf. (%)
€34.35
22.12.22
-
22.12.23
13.25%
24.08.23

buy
Sartorius AG VZO

Start price
Target price
Perf. (%)
€344.30
21.07.23
-
21.08.23
1.57%
22.08.23

buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€1.28
06.08.23
-
06.08.24
-12.50%
20.08.23

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€30.17
11.08.23
-
11.08.24
-3.38%
19.08.23

buy
Bayer AG

Start price
Target price
Perf. (%)
€50.42
13.07.23
€60.00
13.08.23
3.91%
14.08.23